Fernando Valiente‐Echeverría

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · Clinical Infectious Diseases · 2021 · 109 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial

María Elvira Balcells, Luis Rojas, Nicole Le Corre et al. · PLoS Medicine · 2021 · 94 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection

Fernando Valiente‐Echeverría, Luca Melnychuk, Kishanda Vyboh et al. · Nature Communications · 2014 · 84 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda

Mónica L. Acevedo, Luis Alonso-Palomares, Andrés Bustamante et al. · medRxiv · 2021 · 81 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors

Maricarmen Vallejos, Jules Deforges, Terra-Dawn Plank et al. · Nucleic Acids Research · 2011 · 72 citations · Full text

Life Sciences, Biology, Molecular Biology +17